Proteomics
- Develop industry scale assays using in-house mass spectrometers
- Execute platform projects centered on PPI mapping, proximity labeling, post-translational modification and abundance proteomics
- Support drug discovery campaigns and develop target-based screens
Genetics
- Develop multimodal single and combinatorial genetic screens using CRISPR technologies
- Collaborate with target discovery teams to provide genetic support for targets and drug MOA
Chemical Biology and Protein Sciences
- Develop HTS small molecule screening campaigns and create robust target assays for drug development
- Drive enzymology, biophysics and protein binding analysis efforts
- Help build out the structural biology platform (including crystallography & Cryo-EM)
- Develop chemical biology tools to map ligandable pockets and aid in drug development
Cancer Biology
- Implement cutting edge molecular and cellular techniques to determine target functions in cell-based solid tumor models
- Develop data packages to prioritize targets and nominate candidates to the drug discovery stage
- Individuals with expertise in oncogene/tumor suppressor pathways and/or drug resistance are especially encouraged to apply
Computational Biology, Data Science
- Develop novel algorithms and apply deep learning-based approaches to network and proteomics datasets
- Implement cloud infrastructure, pipelines, and UI/UX for data analytics
- Conduct bioinformatic and statistical analyses of large, multimodal datasets
Skills Required
- Experience with mass spectrometers
- Experience with CRISPR technologies
- Skills in bioinformatics and statistical analysis
- Expertise in molecular and cellular techniques
- Ability to develop algorithms for deep learning
What We Do
Rezo is a different kind of biopharma company. Our mission is to dramatically increase the success rate of drug development by building a disease-agnostic, fully-integrated, network biology platform that will redefine our understanding of human disease and ability to treat it. Our Founders and members of the Board are a group of esteemed, world-class scientists from the University of California, San Francisco: Nevan Krogan, Kevan Shokat, Sourav Bandyopadhyay, Natalia Jura, as well as renowned biotech executives George Scangos and Norbert Bischofberger. These leaders bring with them a strong track record of amazing discoveries and scientific breakthroughs, leading to very successful companies and many FDA approved drugs.

.png)





